|
Main | | | | | | | | | | | | | | | | |
| CEO | Ian Read | Jeff Kindler | Hank McKinnell | Bill Steere | Ed Pratt | | | | | | | | | | |
| CFO | Frank D'Amelio | | | | | | | | | | | | | | |
| Established Products | Olivier Brandicourt | David Simmons | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| Chinese salesforce of 3500 in 177 cities. | | | | | | | | | | | | | | | |
| China sales roughly $1bn in 2009 - GS | | | | | | | | | | | | | | | |
| China healthcare spend is 4.5% of GDP. | | | | | | | | | | | | | | | |
| Norvasc grew 28% y/y in China in 2008 - GS. | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| $165m total expenditures on healthcare in China in 2007, $125 per capita. | | | | | | | | | | | | | | | |
| $5,711 in US, $3k in germany, $2.2k in Japan. | | | | | | | | | | | | | | | |
| $92bn chinese pharmaceutical industry: 28% API, 34% pharma, 9% biotech, 29% traditional. | | | | | | | | | | | | | | | |
| 80% of drugs dispensed through hospital pharmacies. | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| Name | Maturity Date | Issue Date | Duration | Amount | Coupon | Price | Yield | Type | Rating | High Yield | High Date | Low Yield | Low Date | Tsys | Spread |
| 2037 5.95% Wyeth | 4/1/2037 | 3/22/2007 | 27 years | 2000 | 0.0595 | 112.127 | 0.0511 | Guaranteed | AA | 8.288 | 10/15/2008 | 4.812 | 12/26/2008 | 0.0402 | 0.0109 |
| 2038 6.5% GBP | 6/3/2038 | 5/27/2009 | 28 years | 1500 | 0.065 | 119.6 | 0.0516 | Senior Unsecured | AA | 6.394 | 5/28/2009 | 5.062 | 8/17/2009 | 0.0403 | 0.011299999999999998 |
| 2039 7.2% | 3/15/2039 | 3/17/2009 | 29 years | 2500 | 0.072 | 129.317 | 0.0522 | Senior Unsecured | AA | 6.949 | 3/25/2009 | 5.21 | 8/28/2009 | 0.0404 | 0.011800000000000005 |